| Gene: | LIMK2 |
| GeneID: | ENSG00000182541 |
| Chrom: | 22 |
| Start position: | 31212239 |
| End position: | 31280080 |
| Pathway: | Fc gamma R-mediated phagocytosis |
| Class: | Organismal Systems; Immune system |
| FST gene level: | 0.146737 |
| Number of nsSNPs: | 2 |
| nsSNPs in gene: | rs3747154
rs5997917 |
| Gene Structure: |  |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.20 | | Gscore (Del): | 0.00 |
|
|
| Recurrently amplified in 1 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
| Recurrently mutated in 1 cancer type(s) |
|
| |
|
|
|
| Functional class: | Kinase (protein kinase) |
| JensenLab PubMed score: | 41.32 (Percentile rank: 59.30%) |
| PubTator score: | 40.05 (Percentile rank: 64.29%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
